{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:58:00Z","timestamp":1774382280005,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Laboratory Medicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.plabm.2020.e00175","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T02:07:48Z","timestamp":1592964468000},"page":"e00175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients"],"prefix":"10.1016","volume":"21","author":[{"given":"R.","family":"Vicente-Steijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bisheshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.-A.","family":"Haagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.plabm.2020.e00175_bib1","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.3748\/wjg.14.5491","article-title":"Inflammatory bowel diseases: a disease (s) of modern times? Is incidence still increasing?","volume":"14","author":"Gismera","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"Suppl A","key":"10.1016\/j.plabm.2020.e00175_bib2","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can. J. Gastroenterol."},{"issue":"Suppl 1","key":"10.1016\/j.plabm.2020.e00175_bib3","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2005.081950a","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.plabm.2020.e00175_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1572-0241.2003.07302.x","article-title":"Patient preferences for CT colonography, conventional colonoscopy, and bowel preparation","volume":"98","author":"Ristvedt","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.plabm.2020.e00175_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/00365520701679116","article-title":"Diagnostic yield of colonoscopy based on symptoms","volume":"43","author":"Lasson","year":"2008","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.plabm.2020.e00175_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/gastro\/gow047","article-title":"Irritable bowel syndrome and diet","volume":"5","author":"Portincasa","year":"2017","journal-title":"Gastroenterol. Rep. (Oxf)"},{"key":"10.1016\/j.plabm.2020.e00175_bib7","first-page":"369","article-title":"Clinicians\u2019 guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease","volume":"29","author":"Bressler","year":"2015","journal-title":"Chin. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.plabm.2020.e00175_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.plabm.2020.e00175_bib9","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"van Rheenen","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.plabm.2020.e00175_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1515\/cclm-2013-0588","article-title":"Inflammatory bowel diseases: from pathogenesis to laboratory testing","volume":"52","author":"Basso","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2020.e00175_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1515\/cclm-2014-0146","article-title":"Inflammatory bowel diseases: where we are and where we should go","volume":"52","author":"Tonutti","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2020.e00175_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365529950172835","article-title":"Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease","volume":"34","author":"Roseth","year":"1999","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.plabm.2020.e00175_bib13","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","article-title":"Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity","volume":"20","author":"Lin","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.plabm.2020.e00175_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/00365529209011186","article-title":"Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study","volume":"27","author":"Roseth","year":"1992","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.plabm.2020.e00175_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1258\/acb.2012.011272","article-title":"Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits","volume":"50","author":"Whitehead","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.plabm.2020.e00175_bib16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1515\/cclm-2016-0796","article-title":"Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease","volume":"55","author":"De Sloovere","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2020.e00175_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1515\/cclm-2013-0699","article-title":"Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics","volume":"52","author":"Oyaert","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2020.e00175_bib18","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1515\/cclm-2016-1012","article-title":"Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease","volume":"55","author":"Oyaert","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2020.e00175_bib19","first-page":"89","article-title":"Calprotectine 2 (TFS) in feces: een nieuwe test","volume":"41","author":"de Koning","year":"2017","journal-title":"Ned. Tijdschr. Klin. Chem. Lab."},{"key":"10.1016\/j.plabm.2020.e00175_bib20","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2126","article-title":"Noninvasive tests for inflammatory bowel disease: a meta-analysis","volume":"137","author":"Holtman","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.plabm.2020.e00175_bib21","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1515\/cclm-2018-0134","article-title":"Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability","volume":"56","author":"Padoan","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2020.e00175_bib22","article-title":"A\u00a0novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers","volume":"31","author":"Nilsen","year":"2016","journal-title":"J.\u00a0Clin. Lab. Anal."},{"key":"10.1016\/j.plabm.2020.e00175_bib23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clinbiochem.2015.10.010","article-title":"Comparison of the Liaison(R) Calprotectin kit with a well established point of care test (Quantum Blue - buhlmann-Alere(R)) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up","volume":"49","author":"Delefortrie","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.plabm.2020.e00175_bib24","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/ibd.20920","article-title":"Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease","volume":"15","author":"Gisbert","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.plabm.2020.e00175_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-8981(99)00206-5","article-title":"Improved assay for fecal calprotectin","volume":"292","author":"Ton","year":"2000","journal-title":"Clin. Chim. Acta"}],"container-title":["Practical Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551720301384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551720301384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:15:49Z","timestamp":1762478149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352551720301384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":25,"alternative-id":["S2352551720301384"],"URL":"https:\/\/doi.org\/10.1016\/j.plabm.2020.e00175","relation":{},"ISSN":["2352-5517"],"issn-type":[{"value":"2352-5517","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients","name":"articletitle","label":"Article Title"},{"value":"Practical Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plabm.2020.e00175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00175"}}